Printer Friendly

TongLi Pharmaceuticals to distribute Ginshen Wubao in US and overseas.

M2 EQUITYBITES-January 4, 2013-TongLi Pharmaceuticals to distribute Ginshen Wubao in US and overseas(C)2013 M2 COMMUNICATIONS

TongLi Pharmaceuticals (USA) Inc (OTCBB:TGLP) announced on Thursday the successful manufacture of Ginshen Wubao, a dietary food supplement, and plans to distribute it to the US domestic and overseas health care markets.

According to the company, research has indicated that the ingredients of the Ginshen Wubao, TongLi's exclusive patented product, can support human immunity, especially for aged people and valetudinarianism. Also, Ginshen Wubao has significant benefits to improve amnesia and insomnia.

Ginshen Wubao, which contains extracts from American Ginseng and Fo-Ti roots, reportedly does not have obvious adverse effects.

((Comments on this story may be sent to

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 4, 2013
Previous Article:API Technologies awarded USD1.0m order to supply specialty connectors for military radios.
Next Article:Echostar names Mahmood S. Mirza as new SVP.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters